Impulse News

Impulse Dynamics Completes $30 Million Financing Round

Mt. Laurel, New Jersey, May 13 2016 – Impulse Dynamics, developer of the Optimizer™ IVs implantable device for treatment of chronic heart failure (CHF), announced today that the company has closed a $30 million financing round. The equity financing round was led by the investment fund of Dr. Peter Lee Ka Kit, Vice Chairman of […]

Mehr dazu

Continued growth within Europe – Impulse Dynamics announces the first implantations of the Optimizer IVs device in the Slovenia.

Stuttgart, Germany, March 2016 Impulse Dynamics announced the first two implantations of its Optimizer IVs device in Slovenia. The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF). The device is based on the innovative Cardiac Contractility Modulation (CCM) technology, which delivers non-excitatory electric pulses to the heart. The […]

Mehr dazu

The Russian Ministry of Public Health approved the Optimizer IVs for clinical application.

Stuttgart, 26.01.2016 – Cardiomedics (Impulse Dynamics authorized distributor in the Russian Federation) announced that the Optimizer IVs has been approved for clinical application by the Ministry of Public Health. Cardiac Contractility Modulation (CCM) is a unique and innovative therapy concept for the treatment of moderate to severe Chronic Heart Failure (CHF). The Optimizer IVs is […]

Mehr dazu

Impulse Dynamics Opens its Hong Kong Sales and Support Office

Hong Kong, China – January 11th, 2016 – Impulse Dynamics NV (Impulse), the developer of the Optimizer™ IVs implantable device, is pleased to announce the official opening of its Hong Kong sales and support office. The Optimizer IVs is a minimally invasive implantable device designed to treat heart failure.  The device is based on novel […]

Mehr dazu

Continued Expansion for Impulse Dynamics’ Optimizer™ IVs Device – First Implant in the Emirate of Sharjah (UAE)

Stuttgart, Germany, November 11th, 2015 – Impulse Dynamics reported today the first implantation of its Optimizer IVs device in the Emirate of Sharjah (UAE). The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF). The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses. The […]

Mehr dazu